Closing Stock Market SummaryThe stock market closed the week on a downbeat note. Ongoing consolidation efforts contributed to some of the weakness, although concerns about global growth prospects were another contributing factor. The major indices hit their best levels in the early afternoon trade as a few mega cap stocks recovered from opening losses, yet selling picked up again to interrupt that rebound effort.
Ultimately, the major indices all closed in negative territory with losses ranging from 0.7% to 1.4%.
The downside moves followed a slate of disappointing preliminary June manufacturing PMIs for Japan, Germany, the UK, the eurozone, and the U.S., all of which came in below 50 (i.e. the dividing line between expansion and contraction). Following yesterday's central bank rate hikes, those reports fueled worries that prior rate hikes may be adversely impacting economic activity, specifically in the manufacturing sector.
Growth concerns manifested themselves in falling commodity prices, the outperformance of the dollar, and sliding Treasury yields. The U.S. Dollar Index rose 0.5% today to 102.91. WTI crude oil futures fell 0.4% to $69.18/bbl and copper futures fell 2.0% to $3.80/lb. The 2-yr note yield fell five basis points to 4.75% and the 10-yr note yield fell six basis points to 3.74%.
Today's retreat in the stock market was broad and orderly. Decliners led advancers by a greater than 2-to-1 margin at both the NYSE and the Nasdaq. 24 of the 30 Dow components logged declines and all 11 S&P 500 sectors closed in the red.
The communication services (-0.3%) sector saw the slimmest loss, boosted by a gain in Meta Platforms (META 288.73, +3.85, +1.4%). Other sectors exhibiting relative strength included the health care (-0.3%) and financials (-0.4%) sectors. Meanwhile, the utilities (-1.5%) and consumer discretionary (-1.1%) sectors fell to the bottom of the pack.
Trading volume was extremely heavy today, reflecting the reconstitution of the Russell Indexes.
- Nasdaq Composite: +28.9% YTD
- S&P 500: +13.3% YTD
- Russell 2000: +3.4% YTD
- S&P Midcap 400: +3.5% YTD
- Dow Jones Industrial Average: +1.8% YTD
Reviewing today's economic data:
- June IHS Markit Manufacturing PMI - Prelim 46.3; Prior 48.4
- June IHS Markit Services PMI - Prelim 54.1; Prior 54.9
There is no U.S. economic data of note on Monday.
"On the forecast track, the system is expected to remain well east and northeast of the northern Leeward Islands through early next week," the NHC said. "Some strengthening is forecast during the next couple of days."
"In light of the new challenges and invaluable experience of the special military operation we will continue to improve the Armed Forces in every possible way," he said, adding that the most important task here was to develop the nuclear triad as the key guarantee of Russia's military security and global stability.Putin also announced that new Sarmat missile launchers would enter duty soon."In the near future, the first launchers of the Sarmat complex with a new heavy missile will be put on combat duty," he said.
Gapping down
In reaction to earnings/guidance:
- XAIR -6.4%
Other news:
- SPCE -10.5% (entered into a distribution agency agreement for the offer and sale of up to $400000000 of shares of common stock)
- ASLN -3.4% (ASLAN Pharmaceuticals announces publication in clinical immunology highlighting Eblasakimab's unique mechanism of action in the treatment of atopic dermatitis)
- TYGO -3% (stock offering relates to warrants)
- TAST -2.9% (stock offering by selling shareholder)
- AVDL -2.6% (JAZZ seeks court action to declare FDA's approval of AVDL's Lumryz as unlawful)
- AKRO -2.6% (Presents Analyses of Phase 2b HARMONY Study at the 2023 International Liver Congress Reinforcing and Characterizing EFX-Related Improvements in Liver Histopathology)
- MSGE -2.4% (prices secondary offering of and concurrent share repurchase)
- GNW -1.8% (discloses security breach)
- JAZZ -1% (JAZZ seeks court action to declare FDA's approval of AVDL's Lumryz as unlawful)
- MRNA -1% (completes submission to FDA for its updated COVID-19 vaccine)
Analyst comments:
- UAA -2.6% (downgraded to Equal Weight from Overweight at Wells Fargo)
- VTRS -2% (downgraded to Underweight from Equal Weight at Barclays)
- ACN -1.4% (downgraded to Market Perform from Outperform at TD Cowen)
Gapping up
In reaction to earnings/guidance:
- APOG +6.6%, KMX +6.1%, SWBI +5.3% (also increases dividend)
Other news:
- TRUP +15.8% (provides update on its rate filing approval status in CA and NY)
- MGTX +9.3% (to present data from Phase 1 AQUAx study and provide update on phase 2 study of AAV-hAQP1)
- IONQ +9.3% (increases its 2023 bookings expectations by 25%)
- GSK +5.4% (provides Zantac litigation update)
- ICPT +4.1% (receives Complete Response Letter from FDA for obeticholic acid as a treatment for pre-cirrhotic fibrosis due to NASH; to restructure to focus on rare and serious liver diseases; significantly reduces operating expenses)
- EGLE +3.9% (to repurchase Oaktree Capital's entire 28% stake for $219.3 mln)
- MMM +3.8% (enters into broad class resolution to support PFAS remediation)
- BC +2.1% (provides update on previously reported IT security incident)
- SAH +1.5% (suspends operations at eight EchoPark locations)
Analyst comments:
- W +2.5% (upgraded to Market Perform from Underperform at MoffettNathanson)



